US equities
|
MU
$878.84
▲+0.00%
AMD
$528.75
▲+0.00%
SNDK
$1,299.30
▲+0.00%
NVDA
$214.13
▲+0.00%
SPCX
$146.03
▲+0.00%
GOOGL
$340.59
▲+0.00%
INTC
$89.85
▲+0.00%
CRWV
$61.39
▲+0.00%
MU
$878.84
▲+0.00%
AMD
$528.75
▲+0.00%
SNDK
$1,299.30
▲+0.00%
NVDA
$214.13
▲+0.00%
SPCX
$146.03
▲+0.00%
GOOGL
$340.59
▲+0.00%
INTC
$89.85
▲+0.00%
CRWV
$61.39
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by SOPHiA GENETICS
SOPHiA GENETICS’ SOPHiA DDM™ HRD Solution is Tapped by Unipath Specialty Laboratory Limited
May 03, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
SOPHiA GENETICS Celebrates Swiss Biotech Award
April 25, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology
April 18, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
Krsnaa Diagnostics is Live on SOPHiA GENETICS
April 11, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
Tel Aviv Sourasky Medical Center Chooses SOPHiA DDMTM HRD Solution of SOPHiA GENETICS
April 04, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test
March 28, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis
March 14, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers
March 06, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
SOPHiA GENETICS Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023
March 03, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing
March 01, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
Synergy Laboratories Taps SOPHiA GENETICS Technology for New Cancer Profiling Solution
February 28, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023
February 23, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug Development
February 13, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies
January 10, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference
January 04, 2023
From
SOPHiA GENETICS
Via
Business Wire
Tickers
SOPH
